Promega builds plant to produce regulated products
Including sample preparation systems and reagents
The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.
‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.
Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.
Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.
You may also like
Analysis
![Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection]()
Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection
Read moreJoint offering creates state-of-the-art workflow uniting Promega’s fast and reliable nucleic acid extraction instrumentation with Countable Labs’ accurate and easy-to-use Countable PCR technology to deliver accuracy across research
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Analysis
![Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection]()
Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection
Joint offering creates state-of-the-art workflow uniting Promega’s fast and reliable nucleic acid extraction instrumentation with Countable Labs’ accurate and easy-to-use Countable PCR technology to deliver accuracy across research
Design & Build
![BioBTX to build commercial-scale plant converting mixed plastic waste into pharmaceutical-grade BTX aromatics]()
BioBTX to build commercial-scale plant converting mixed plastic waste into pharmaceutical-grade BTX aromatics
The Delfzijl facility will process 20,000 tonnes of mixed plastic waste annually using catalytic pyrolysis, cutting BTX production emissions by up to 80% versus fossil-based routes — with Covestro as a strategic partner
Manufacturing
![ACG brings patient-friendly access and ultra-high barrier protection together in blister packaging]()
ACG brings patient-friendly access and ultra-high barrier protection together in blister packaging
ACG’s CR/SF lidding foil and Ultrasafe thermoformable film address two critical blister-packaging requirements: making individual doses accessible to intended users while protecting formulations from oxygen and moisture
Manufacturing
![SGS expands French bioanalytical laboratory to support complex drug development programmes]()
SGS expands French bioanalytical laboratory to support complex drug development programmes
SGS has expanded its Saint-Benoit bioanalytical laboratory near Poitiers, France, increasing capacity for pharma and biotech companies developing small molecules, biologics and advanced therapies